{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:21:10Z","timestamp":1790310070835,"version":"4.1.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T00:00:00Z","timestamp":1422403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0115476","type":"journal-article","created":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T18:50:54Z","timestamp":1422471054000},"page":"e0115476","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization"],"prefix":"10.1371","volume":"10","author":[{"given":"Surender","family":"Khurana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Manischewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Ishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Gurwith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Golding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,1,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1473-3099(11)70240-7","article-title":"DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials","volume":"11","author":"JE Ledgerwood","year":"2011","journal-title":"The Lancet infectious diseases"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Talaat KR, Luke CJ, Khurana S, Manischewitz J, King LR, et al. A live attenuated H5N1 vaccine induces long-term immunity in the absence of a primary antibody response. J Infect Dis. 2014.","DOI":"10.1093\/infdis\/jiu123"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1473-3099(12)70345-6","article-title":"Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study","volume":"13","author":"M Gurwith","year":"2013","journal-title":"The Lancet infectious diseases"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"85ra48","DOI":"10.1126\/scitranslmed.3002336","article-title":"MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines","volume":"3","author":"S Khurana","year":"2011","journal-title":"Sci Transl Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JCM.37.4.937-943.1999","article-title":"Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays","volume":"37","author":"T Rowe","year":"1999","journal-title":"J Clin Microbiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa055778","article-title":"Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine","volume":"354","author":"JJ Treanor","year":"2006","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/infdis\/jir791","article-title":"Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender","volume":"205","author":"S Khurana","year":"2011","journal-title":"J Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1128\/JVI.02107-10","article-title":"Bacterial HA1 vaccine against pandemic H5N1 influenza virus: evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets","volume":"85","author":"S Khurana","year":"2010","journal-title":"J Virol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e11548","DOI":"10.1371\/journal.pone.0011548","article-title":"Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virus","volume":"5","author":"S Khurana","year":"2010","journal-title":"PLoS ONE"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"12283","DOI":"10.1128\/JVI.01596-12","article-title":"Oligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild-type H5N1 influenza challenge and controls viral loads better than subunit H5N1 vaccine by eliciting high-affinity antibodies","volume":"86","author":"S Verma","year":"2012","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"15ra5","DOI":"10.1126\/scitranslmed.3000624","article-title":"Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus","volume":"2","author":"S Khurana","year":"2010","journal-title":"Science Translational Medicine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e1002920","DOI":"10.1371\/journal.ppat.1002920","article-title":"AID activity in B cells strongly correlates with polyclonal antibody affinity maturation in-vivo following pandemic 2009-H1N1 vaccination in humans","volume":"8","author":"S Khurana","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/infdis\/jit178","article-title":"DNA priming prior to inactivated influenza A(H5N1) vaccination expands the antibody epitope repertoire and increases affinity maturation in a boost-interval-dependent manner in adults","volume":"208","author":"S Khurana","year":"2013","journal-title":"J Infect Dis"},{"key":"ref14","first-page":"71","article-title":"Adenovirus vectored vaccines","volume":"82","author":"RJ Natuk","year":"1994","journal-title":"Dev Biol Stand"},{"key":"ref15","first-page":"153","article-title":"Adenovirus as vector for HIV: efficacy and safety issues","volume":"84","author":"RJ Natuk","year":"1995","journal-title":"Dev Biol Stand"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nm0697-651","article-title":"Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization","volume":"3","author":"MD Lubeck","year":"1997","journal-title":"Nature medicine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1128\/JVI.72.2.1052-1059.1998","article-title":"Induction of neutralizing antibodies to T-cell line-adapted and primary human immunodeficiency virus type 1 isolates with a prime-boost vaccine regimen in chimpanzees","volume":"72","author":"S Zolla-Pazner","year":"1998","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.86.17.6763","article-title":"Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus","volume":"86","author":"MD Lubeck","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0008-8749(87)90291-7","article-title":"Persistence of influenza virus-specific antibody-secreting cells and B-cell memory after primary murine influenza virus infection","volume":"109","author":"PD Jones","year":"1987","journal-title":"Cell Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0264-410X(87)90109-5","article-title":"Influenza-specific antibody-secreting cells and B cell memory in the murine lung after immunization with wild-type, cold-adapted variant and inactivated influenza viruses","volume":"5","author":"PD Jones","year":"1987","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1128\/JVI.68.9.6083-6086.1994","article-title":"Respiratory virus infection of mice provokes a permanent humoral immune response","volume":"68","author":"L Hyland","year":"1994","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1241146","article-title":"Diversity among memory B cells: origin, consequences, and utility","volume":"341","author":"D Tarlinton","year":"2013","journal-title":"Science"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1084\/jem.20110740","article-title":"Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants","volume":"208","author":"WE Purtha","year":"2011","journal-title":"J Exp Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.20101352","article-title":"Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection","volume":"208","author":"J Wrammert","year":"2011","journal-title":"J Exp Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/JVI.02077-13","article-title":"CD4 T cell help is limiting and selective during the primary B cell response to influenza virus infection","volume":"88","author":"S Alam","year":"2014","journal-title":"J Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.vaccine.2009.10.103","article-title":"Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice","volume":"28","author":"J Alexander","year":"2010","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e4384","DOI":"10.1371\/journal.pone.0004384","article-title":"MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults","volume":"4","author":"A Banzhoff","year":"2009","journal-title":"PLoS ONE"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-065X.2010.00974.x","article-title":"Influenza vaccine immunology","volume":"239","author":"PR Dormitzer","year":"2011","journal-title":"Immunol Rev"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1586\/erv.11.192","article-title":"Development and evaluation of AS03, an Adjuvant System containing alpha-tocopherol and squalene in an oil-in-water emulsion","volume":"11","author":"N Garcon","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10875-010-9490-6","article-title":"H5N1 influenza vaccine formulated with AS03 A induces strong cross-reactive and polyfunctional CD4 T-cell responses","volume":"31","author":"P Moris","year":"2010","journal-title":"J Clin Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1073\/pnas.0813390106","article-title":"Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels","volume":"106","author":"G Galli","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"14330","DOI":"10.1073\/pnas.1311998110","article-title":"Human circulating influenza-CD4+ ICOS1+IL-21+ T cells expand after vaccination, exert helper function, and predict antibody responses","volume":"110","author":"F Spensieri","year":"2013","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0115476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T12:08:27Z","timestamp":1598702907000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0115476"}},"subtitle":[],"editor":[{"given":"Ray","family":"Borrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,1,28]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,1,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0115476","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,28]]}}}